Cardlytics (CDLX) EBITDA margin US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | -21.1% | -33.7% | -139.9% | -140.3% | -32.0% | -81.4% | ||
Changes by years, y/y, % | -15pp | -13pp | -106pp | 0pp | +108pp | +9.3% |
Cardlytics. EBITDA margin, %
Cardlytics. EBITDA margin, changes, pp
Cardlytics (CDLX) EBITDA margin US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
EBITDA margin, % | ? | -19.8% | -103.4% | -24.6% | 7.51% | -201.8% | -81.4% | |
Changes by years, y/y, % | +14pp | -81pp | +11pp | +25pp | -182pp | |||
Changes by quarters, q/q, % | -2pp | -84pp | +79pp | +32pp | -209pp |